Current position:Home >Product >
4,7-Epoxyisobenzofuran-5-carboxylic acid, octahydro-1,3-dioxo-, (3a-al pha,4-beta,5-alpha,7-beta,7a-alpha)-
4,7-Epoxyisobenzofuran-5-carboxylic acid, octahydro-1,3-dioxo-, (3a-al pha,4-beta,5-alpha,7-beta,7a-alpha)-(127311-90-4)
- Name: 4,7-Epoxyisobenzofuran-5-carboxylic acid, octahydro-1,3-dioxo-, (3a-al pha,4-beta,5-alpha,7-beta,7a-alpha)-
- Synonyms:
- Molecular Formula:C9H8 O6
- Molecular Weight:212.156
- CAS Registry Number:127311-90-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.127311-90-4 4,7-Epoxyisobenzofuran-5-carboxylic acid, octahydro-1,3-dioxo-, (3a-al pha,4-beta,5-alpha,7-beta,7a-alpha)-
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.127311-90-4 4,7-Epoxyisobenzofuran-5-carboxylicacid, octahydro-1,3-dioxo-, (3aa,4b,5a,7b,7aa)- (9CI)
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 133526-80-4/2-hydroxy-4-({[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]acetyl}amino)benzoic acid
- 32473-29-3/Poly[imino(1,5-dioxo-1,5-pentanediyl)imino-1,- 5-pentanediyl]
- 179981-97-6/Saikosaponin Q (Bupleurum subovatum)
- 26655-24-3/1,3-Isobenzofurandione, polymer with 1,2,3-propanetriol
- 29926-41-8/2-Acetyl-2-thiazoline
- 74038-25-8/Tris[4-(methylthio)phenyl]phosphine sulfide
- 281-23-2/Adamantane
- 81717-28-4/N-heptyl-N-[4-[(heptylcarbamoylformyl)amino]phenyl]sulfonyl-oxamide
- 5424-96-4/N-(4-chlorobenzyl)-N,N-dimethyl-2-[(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino]ethanaminium
- 26777-62-8/Hexanedioic acid, polymer with azacyclotridecan-2-one, hexahydro-2H-azepin-2-one and 1,6-hexanediamine
- 81514-37-6/1-[4-[2-[(4-amino-5-chloro-2-methoxy-phenyl)sulfonylamino]ethyl]phenyl ]sulfonyl-3-propyl-urea
- 6635-98-9/4-[2-(1H-indazol-5-yl)hydrazino]-5H-indazol-5-one
- 20407-84-5/TRANS-2-DODECENAL
- 30419-67-1/(2R,2'R)-2β,2'β-Bi[oxirane]
- 74887-69-7/N-(4,5-dihydro-1,3-oxazol-2-yl)-2,3-dihydro-1H-indol-1-amine
- 10593-85-8/HOMOCYSTEINE THIOLACTONE
- 169317-96-8/L-Glutamic acid,N-[4-[4-(2,4-diamino-5-pyrimidinyl)butyl]benzoyl]-
- 9012-93-5/Chelataseferro-protoporphyrin
- 116850-45-4/3-(ethylsulfonyl)-4-methyl-5-phenyl-4H-1,2,4-triazole
- 127311-90-4/4,7-Epoxyisobenzofuran-5-carboxylic acid, octahydro-1,3-dioxo-, (3a-al pha,4-beta,5-alpha,7-beta,7a-alpha)-
- 375823-41-9/Tocilizumab
- 7468-57-7/1-(2,6-diphenyltetrahydro[1,3]dioxino[5,4-d][1,3]dioxin-4-yl)-2-iodoethyl 4-methylbenzenesulfonate (non-preferred name)
- 13510-35-5/INDIUM(III) IODIDE
- 78213-65-7/15-Deoxypenitrem A
- 78265-99-3/N,N-diethyl-3-[(2-phenylheptanoyl)oxy]propan-1-aminium chloride
- 2668-47-5/2,6-di-tert-butyl-4-phenylphenol
- 68892-09-1/4-[(4Z)-4-{[2-chloro-4-(dimethylamino)phenyl]methylidene}-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]benzoic acid
- 114390-31-7/aconityldoxorubicin
- 85049-39-4/Fatty acids, C16-18 and C18-unsatd., tridecyl esters
- 15475-51-1/(1R,5S)-3-[(3-bromo-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane (2Z)-but-2-enedioate